Evidence map›Paper›PMID 39763866›Full record

ArticlebioRxiv : the preprint server for biology2025

A signaling inspired synthetic toolkit for efficient production of tyrosine phosphorylated proteins.

Margaret M Ryan, Reagan Portelance, Graham F Newman, Gabrielle Martinez, Swathi Shekharan, Anqi Wu, Savannah Angel, Katherine E Schaberg, Petra Gilmore, Robert Sprung and 2 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Margaret M RyanUniversity of Virginia, Department of Biomedical Engineering and the Department of Genome Sciences, Charlottesville, VA, 22903.
Reagan PortelanceUniversity of Virginia, Department of Biomedical Engineering and the Department of Genome Sciences, Charlottesville, VA, 22903.
Graham F NewmanUniversity of Virginia, Department of Biomedical Engineering and the Department of Genome Sciences, Charlottesville, VA, 22903.
Gabrielle MartinezUniversity of Virginia, Department of Biomedical Engineering and the Department of Genome Sciences, Charlottesville, VA, 22903.
Swathi ShekharanUniversity of Virginia, Department of Biomedical Engineering and the Department of Genome Sciences, Charlottesville, VA, 22903.
Anqi WuUniversity of Virginia, Department of Biomedical Engineering and the Department of Genome Sciences, Charlottesville, VA, 22903.
Savannah AngelUniversity of Virginia, Department of Biomedical Engineering and the Department of Genome Sciences, Charlottesville, VA, 22903.
Katherine E SchabergWashington University in St. Louis, Department of Biomedical Engineering, St. Louis, MO 63130.
Petra GilmoreWashington University in St. Louis, Medicine and Molecular Biology and Pharmacology, St. Louis, MO 63130.
Robert SprungWashington University in St. Louis, Medicine and Molecular Biology and Pharmacology, St. Louis, MO 63130.
Reid TownsendWashington University in St. Louis, Medicine and Molecular Biology and Pharmacology, St. Louis, MO 63130.
Kristen M NaegleUniversity of Virginia, Department of Biomedical Engineering and the Department of Genome Sciences, Charlottesville, VA, 22903.ORCID 0000-0001-7146-9592

Funding

A synthetic toolkit for the recombinant production of tyrosine phosphorylated proteins and peptidesR33CA259451 · NCI · UNIVERSITY OF VIRGINIA · PI NAEGLE, KRISTEN M · 2022 to 2024
$1.1M
A MOLECULAR TOOLKIT FOR THE PRODUCTION OF TYROSINE PHOSPHORYLATED PROTEINSR21CA212726 · NCI · WASHINGTON UNIVERSITY · PI NAEGLE, KRISTEN M · 2017 to 2019
$615k
NCI NIH HHS R21 CA212726NCI NIH HHS R33 CA259451
6 · The paper itself

Abstract

Tyrosine phosphorylation is an important post-translational modification that regulates many biochemical signaling networks in multicellular organisms. To date, 46,000 tyrosines have been observed in human proteins, but relatively little is known about the function and regulation of most of these sites. A major challenge has been producing recombinant phosphoproteins in order to test the effects of phosphorylation. Mutagenesis to acidic amino acids often fails to replicate the size and charge of a phosphorylated tyrosine residue and synthetic amino acid incorporation has high cost with relatively low yield. Here, we demonstrate an approach, inspired by how native tyrosine kinases find targets in cells - through a secondary targeting interaction, augmenting innate catalytic specificity of a tyrosine kinase, without overriding it. We engineered complementary vector systems for multiple approaches to producing high yields of phosphoprotein products in E. coli. Here, we test phosphorylation as a function of the targeting interaction (an SH3-polyproline sequence) affinity, different reaction methods across kinases of different specificity. This system presents an inexpensive and tractable system to producing phosphoproteins and phosphopeptides and we demonstrate how it can be used for testing antibody specificity on targets of EGFR and PD-1. This methodology is a generalizable approach for enhancing the enzymatic action on a recombinant protein via the flexibility of in vitro reactions and co-expression approaches. We refer to this as SISA-KiT, for Signaling Inspired Synthetically Augmented Kinase Toolkit.

Identifiers

PMID39763866
PMCPMC11703254

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.